序号 |
标题 |
次数 |
作者 |
发布时间 |
169426 |
反式-2-(3-(苄氧基)苯基)环丙基甲醇,PROTAC(蛋白降解靶向嵌合体) |
171 |
kx |
2024-03-04 |
169427 |
890091-43-7 Amine-PEG9-NH-Boc 氨基-九聚乙二醇-叔丁氧羰基 |
181 |
wqy |
2024-03-04 |
169428 |
222983-64-4 4-(6-羟基己-1-炔-1-基)苯甲酸甲酯 PROTAC(蛋白降解靶向嵌合体) |
199 |
zcy |
2024-03-04 |
169429 |
705250-92-6,31 反式-2-(3-(三氟甲氧基)苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
186 |
kx |
2024-03-04 |
169430 |
Gold nanoparticles,Au-PEG-Cholesterol(30nm)胆固醇修饰纳米金30nm |
165 |
zyl |
2024-03-04 |
169431 |
474082-35-4 Amine-PEG10-amine 氨基十聚乙二醇乙胺 |
180 |
wqy |
2024-03-04 |
169432 |
4-(4-(甲氧基羰基)苯乙基)哌嗪-1-羧酸叔丁酯 tert-butyl 4-(4-(methoxycarbonyl)phenethyl) piperazine-1-carboxylate PROTAC |
191 |
zcy |
2024-03-04 |
169433 |
Gold nanoparticles,Au-PEG-Cholesterol(20nm)胆固醇修饰纳米金20nm |
161 |
zyl |
2024-03-04 |
169434 |
2055014-94-1 Propargyl-PEG8-acid;Propargyl-PEG8-COOH 丙炔-八乙二醇-羧酸 |
174 |
wqy |
2024-03-04 |
169435 |
反式-2-(3-硝基-4-(三氟甲氧基)苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
185 |
kx |
2024-03-04 |
169436 |
COOtBu-PEG8-DNP;DNP-PEG8-t-butyl ester |
190 |
wqy |
2024-03-04 |
169437 |
反式-2-(3-氰基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
194 |
kx |
2024-03-04 |
169438 |
1007209-94-0 4-(4-溴苯乙基)哌嗪-1-羧酸叔丁酯 PROTAC(蛋白降解靶向嵌合体) |
196 |
zcy |
2024-03-04 |
169439 |
Boc-NH-PEG8-DNP 分子式 C29H50N4O14 |
184 |
wqy |
2024-03-04 |
169440 |
84913-19-9 4-甲基苯磺酸4-溴苯乙酯 PROTAC(蛋白降解靶向嵌合体) |
216 |
zcy |
2024-03-04 |
169441 |
16633-45-7,93 反式-2-(3-氯苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
188 |
kx |
2024-03-04 |
169442 |
Gold nanoparticles,Au-PEG-Cholesterol(15nm)胆固醇修饰纳米金15nm |
172 |
zyl |
2024-03-04 |
169443 |
2227899-38-7,63 反式-2-(3-氯-5-氟苯基)环丙烷-1-羧酸 ,PROTAC(蛋白降解靶向嵌合体) |
214 |
kx |
2024-03-04 |
169444 |
4-氯-N-(2-(2,6-二氧杂哌啶-3-基)-1,3-二氧异吲哚-4-基)丁酰胺 4-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)butanamide PROTAC |
216 |
zcy |
2024-03-04 |
169445 |
Azide-PEG8-DNP 分子式 C24H40N6O12 |
183 |
wqy |
2024-03-04 |
169446 |
Gold nanoparticles,Au-PEG-Cholesterol(10nm)胆固醇修饰纳米金10nm |
203 |
zyl |
2024-03-04 |
169447 |
COOtBu-PEG8-DNP;DNP-PEG8-t-butyl ester |
174 |
wqy |
2024-03-04 |
169448 |
4-氯-N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧异吲哚-5-基)丁酰胺 4-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)butanamide PROTAC |
212 |
zcy |
2024-03-04 |
169449 |
Boc-NH-PEG8-DNP C29H50N4O14 |
184 |
wqy |
2024-03-04 |
169450 |
Gold nanoparticles,Au-PEG-Cholesterol(10nm)胆固醇修饰纳米金10nm |
170 |
zyl |
2024-03-04 |
169451 |
2227914-40-9,69 反式-2-(3-氯-5-氟苯基)环丙-1-胺盐酸盐,PROTAC(蛋白降解靶向嵌合体) |
196 |
kx |
2024-03-04 |
169452 |
220353-93-5,65 反式-2-(3-氯-4-甲基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
223 |
kx |
2024-03-04 |
169453 |
51908-64-6 4-氯-1-丁炔 PROTAC(蛋白降解靶向嵌合体) |
226 |
zcy |
2024-03-04 |
169454 |
Amine-PEG8-DNP 分子式 C24H42N4O12 |
200 |
wqy |
2024-03-04 |
169455 |
Gold nanoparticles,Au-PEG-Cholesterol(5nm)胆固醇修饰纳米金5nm |
208 |
zyl |
2024-03-04 |
169456 |
2055042-66-3 Hydroxy-PEG9-t-butyl ester 羟基九聚乙二醇丙酸叔丁酯 |
165 |
wqy |
2024-03-04 |
169457 |
反式-2-(3-氟-5-(三氟甲基)苯基)环丙基)甲醇,PROTAC(蛋白降解靶向嵌合体) |
192 |
kx |
2024-03-04 |
169458 |
chitosan modified Au nanoparticles(100nm)壳聚糖修饰金纳米颗粒(100nm) |
198 |
zyl |
2024-03-04 |
169459 |
6790-9-6 Dodecaethylene glycol 十二聚乙二醇 |
197 |
wqy |
2024-03-04 |
169460 |
1334170-02-3 NHS-PEG7-NHS ester;活性酯七聚乙二醇活性酯 |
187 |
wqy |
2024-03-04 |
169461 |
63200-68-0 4-氨基丁-2-炔-1-醇 PROTAC(蛋白降解靶向嵌合体) |
176 |
zcy |
2024-03-04 |
169462 |
1609290-12-1,80 反式-2-(3-氟-4-甲氧基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
196 |
kx |
2024-03-04 |
169463 |
1333154-77-0 azido-PEG7-amine;叠氮七聚乙二醇氨基 |
192 |
wqy |
2024-03-04 |
169464 |
887587-18-0 4-(哌嗪-1-羰基)哌啶-1-羧酸叔丁酯 PROTAC(蛋白降解靶向嵌合体) |
218 |
zcy |
2024-03-04 |
169465 |
94376-75-7 Bis-PEG7-acid;Acid-PEG-acid 羧基七聚乙二醇羧基 |
200 |
wqy |
2024-03-04 |
169466 |
211859-75-5 m-PEG10-OTs;甲氧基-十聚乙二醇-对甲苯磺酸酯 |
190 |
wqy |
2024-03-04 |
169467 |
反式-2-(3-乙基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
197 |
kx |
2024-03-04 |
169468 |
2168540-65-4 mPEG11-OH 十一聚乙二醇单甲醚 |
189 |
wqy |
2024-03-04 |
169469 |
chitosan modified Au nanoparticles(80nm)壳聚糖修饰金纳米颗粒(80nm) |
224 |
zyl |
2024-03-04 |
169470 |
2308496-47-9 4-(哌啶-4-基乙炔基)苯甲酸甲酯 PROTAC(蛋白降解靶向嵌合体) |
174 |
zcy |
2024-03-04 |